Characterization of a Novel Human Immunodeficiency Virus Type 1 Neutralizable Epitope within the Immunodominant Region of gp41

By Viveros M.   Dickey C.   Cotropia J.P.   Gevorkian G.   Larralde C.   Broliden K.   Levi M.   Burgess A.   Cao C.   Weiner D.B.   Agadjanyan M.G.   Ugen K.E.  

Virology, Vol. 270, Iss. 1, 2000-04 ,pp. : 135-145

Elsevier

Access to resources Recommend Favorite

Immunogenic and Antigenic Dominance of a Nonneutralizing Epitope over a Highly Conserved Neutralizing Epitope in the gp41 Envelope Glycoprotein of Human Immunodeficiency Virus Type 1: Its Deletion Leads to a Strong Neutralizing Response

By Cleveland S.M.   Buratti E.   Jones T.D.   North P.   Baralle F.   McLain L.   McInerney T.   Durrani Z.   Dimmock N.J.  

Virology, Vol. 266, Iss. 1, 2000-01 ,pp. : 66-78

Elsevier

Access to resources Recommend Favorite

Small Amino Acid Changes in the V3 Loop of Human Immunodeficiency Virus Type 2 Determines the Coreceptor Usage for CXCR4 and CCR5

By Isaka Y.   Sato A.   Miki S.   Kawauchi S.   Sakaida H.   Hori T.   Uchiyama T.   Adachi A.   Hayami M.   Fujiwara T.   Yoshie O.  

Virology, Vol. 264, Iss. 1, 1999-11 ,pp. : 237-243

Elsevier

Access to resources Recommend Favorite

Immunogenicity and Ability of Variable Loop-Deleted Human Immunodeficiency Virus Type 1 Envelope Glycoproteins to Elicit Neutralizing Antibodies

By Kim Y.B.   Han D.P.   Cao C.   Cho M.W.  

Virology, Vol. 305, Iss. 1, 2003-01 ,pp. : 124-137

Academic Press

Access to resources Recommend Favorite

A longitudinal assessment of autologous neutralizing antibodies in children perinatally infected with human immunodeficiency virus type 1

By Geffin R.   Hutto C.   Andrew C.   Scott G.B.  

Virology, Vol. 310, Iss. 2, 2003-06 ,pp. : 207-215

Elsevier

Access to resources Recommend Favorite